Lupin appoints head of corporate development
This article was originally published in Scrip
Mumbai, India-based Lupin, a pharmaceutical company developing a range of branded and generic formulations and APIs, has named Theresa Stevens chief corporate development officer for its global operations. Prior to joining Lupin, Ms Stevens was chief corporate development officer, responsible for mergers and acquisitions at Aptalis pharma. Furthermore, Ms Stevens previously worked at big pharma Novartis for more than 9 years in various management positions.
You may also be interested in...
Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives.
A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.